Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Chegg
CHGG
$110M
| $2.51M | ﹤0.01% |
792,930
-153,651
| -16% | -$763K |
|
2627
Honda
HMC
$39.1B
| $2.5M | ﹤0.01% |
77,396
+15,305
| +25% | +$518K |
|
|
SPNS
2628
DELISTED
Sapiens International
SPNS
| $2.49M | ﹤0.01% |
73,289
+3,677
| +5% | +$120K |
|
2629
Treace Medical Concepts
TMCI
$280M
| $2.48M | ﹤0.01% |
373,250
+14,900
| +4% | +$120K |
|
2630
Theravance Biopharma
TBPH
$874M
| $2.47M | ﹤0.01% |
291,266
-19,235
| -6% | -$174K |
|
|
CTEV
2631
Claritev Corp
CTEV
$387M
| $2.47M | ﹤0.01% |
158,742
-53,268
| -25% | -$1.27M |
|
2632
Ribbon Communications
RBBN
$377M
| $2.46M | ﹤0.01% |
748,908
+54,594
| +8% | +$166K |
|
|
NVRO
2633
DELISTED
NEVRO CORP.
NVRO
| $2.46M | ﹤0.01% |
292,306
+43,412
| +17% | +$463K |
|
|
WSR
2634
DELISTED
Whitestone REIT
WSR
| $2.46M | ﹤0.01% |
184,840
+10,543
| +6% | +$130K |
|
2635
Bally's
BALY
$682M
| $2.46M | ﹤0.01% |
205,218
-24,852
| -11% | -$318K |
|
2636
GoPro
GPRO
$130M
| $2.45M | ﹤0.01% |
1,725,164
-282,063
| -14% | -$471K |
|
2637
FTAI Infrastructure
FIP
$441M
| $2.45M | ﹤0.01% |
283,797
+18,660
| +7% | +$142K |
|
2638
AB InBev
BUD
$167B
| $2.44M | ﹤0.01% |
42,033
+6,351
| +18% | +$389K |
|
2639
Aehr Test Systems
AEHR
$2.61B
| $2.43M | ﹤0.01% |
217,690
+5,583
| +3% | +$65K |
|
2640
Axogen
AXGN
$2.27B
| $2.43M | ﹤0.01% |
335,105
-11,848
| -3% | -$81K |
|
2641
NewtekOne
NEWT
$428M
| $2.41M | ﹤0.01% |
192,073
+4,761
| +3% | +$58.6K |
|
2642
Taboola.com
TBLA
$1.37B
| $2.41M | ﹤0.01% |
700,205
-206,347
| -23% | -$833K |
|
2643
FuelCell Energy
FCEL
$1.73B
| $2.4M | ﹤0.01% |
125,377
+12,363
| +11% | +$332K |
|
2644
Rogers Communications
RCI
$18.3B
| $2.4M | ﹤0.01% |
+64,789
| New | +$2.51M |
|
2645
Financial Institutions
FISI
$816M
| $2.4M | ﹤0.01% |
124,011
+2,059
| +2% | +$36.5K |
|
2646
Barclays
BCS
$92.7B
| $2.39M | ﹤0.01% |
223,524
+57,041
| +34% | +$593K |
|
2647
Lloyds Banking Group
LYG
$89.5B
| $2.39M | ﹤0.01% |
875,406
+278,349
| +47% | +$747K |
|
2648
Mineralys Therapeutics
MLYS
$2.25B
| $2.39M | ﹤0.01% |
203,935
+83,073
| +69% | +$1.05M |
|
2649
Ceco Environmental
CECO
$3.85B
| $2.38M | ﹤0.01% |
82,604
+3,348
| +4% | +$81.1K |
|
2650
Build-A-Bear
BBW
$425M
| $2.38M | ﹤0.01% |
94,242
-6,812
| -7% | -$192K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.